why choose us

First received: November 01, 2023

Clinical Trial: A Study of LY3872386 in Healthy Participants and Participants With Atopic Dermatitis

Study Status: NOT_YET_RECRUITING

Recruit Status: NOT_YET_RECRUITING

Condition: Healthy

Study Type: INTERVENTIONAL


Official Title: A Phase 1, Multicenter, Randomized, Placebo-Controlled, Double-Blind, Single-Ascending Dose Study of LY3872386 in Healthy Participants, a Multiple-Ascending Dose Study of LY3872386 in Patients With At

Brief Summary: The main purpose of this study is to evaluate the safety and tolerability of LY3872386 in healthy participants and participants with atopic dermatitis.The safety of prednisone is also evaluated in healthy participants.Blood tests will be performed to investigate how the body processes the LY3872386 following single and multiple dosing in healthy participants and participants with atopic dermatitis.Blood tests will also be performed to investigate how the body processes the prednisone in healthy participants.The…

Read more